Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase NA 2Phase 1/2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 2

Interventions

Cytarabine 19Cyclophosphamide 18venetoclax 15fludarabine phosphate 14Busulfan 14Cyclosporine 12Azacitidine 11fludarabine 10Peripheral Blood Stem Cell Transplantation 10Granulocyte Colony-Stimulating Factor 10Mycophenolic Acid 9Filgrastim 9Melphalan 8Antilymphocyte Serum 8Whole-Body Irradiation 7Palliative Care 7Idarubicin 6Blood Specimen Collection 6Methotrexate 5Therapeutics 4Specimen Handling 4Radiotherapy 4Methods 4Early Intervention, Educational 4Daunorubicin 4Cord Blood Stem Cell Transplantation 4thymoglobulin 3Thiotepa 3Tacrolimus 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myeloid, Acute × Aclarubicin × Clear all
NCT05258799 2022-02-28

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study

Shengjing Hospital

Phase NA Unknown
130 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04168138 2019-11-19

D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients

Shengjing Hospital

Phase NA Unknown
20 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡